DIMITRA BOURBOULIA

Dr. DIMITRA BOURBOULIA

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Cell Reports
Verified
Journal Article
Open access
ABAlexander J. Baker-Williams
Alexander J. Baker-Williams
FHFiza Hashmi
Fiza Hashmi
MBMarek A. Budzyński
Marek A. Budzyński
MWMark R Woodford
Mark R Woodford
SGStephanie Gleicher
Stephanie Gleicher
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
The extracellular molecular chaperone heat shock protein 90 (eHSP90) stabilizes protease client the matrix metalloproteinase 2 (MMP2), leading to tumor cell invasion. Although co-chaperones are critical modulators of intracellular HSP90:client function, how the eHSP90:MMP2 complex is regulated remains speculative. Here, we report that the tissue inhibitor of metalloproteinases-2 (TIMP2) is a stress-inducible extracellular co-chaperone that binds to eHSP90, increases eHSP90 binding to ATP, and inhibits its ATPase activity. In addition to disrupting the eHSP90:MMP2 complex and terminally inactivating MMP2, TIMP2 loads the client to eHSP90, keeping the protease in a transient inhibitory state. Secreted activating co-chaperone AHA1 displaces TIMP2 from the complex, providing a "reactivating" mechanism for MMP2. Gene knockout or blocking antibodies targeting TIMP2 and AHA1 released by HT1080 cancer cells modify their gelatinolytic activity. Our data suggest that TIMP2 and AHA1 co-chaperones function as a molecular switch that determines the inhibition and reactivation of the eHSP90 client protein MMP2.

4 June 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
LWLaura A. Wengert
Laura A. Wengert
SBSarah J Backe
Sarah J Backe
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
MMMehdi Mollapour
Mehdi Mollapour
MWMark R Woodford
Mark R Woodford
Mitochondrial function is dependent on molecular chaperones, primarily due to their necessity in the formation of respiratory complexes and clearance of misfolded proteins. Heat shock proteins (Hsps) are a subset of molecular chaperones that function in all subcellular compartments, both constitutively and in response to stress. The Hsp90 chaperone TNF-receptor-associated protein-1 (TRAP1) is primarily localized to the mitochondria and controls both cellular metabolic reprogramming and mitochondrial apoptosis. TRAP1 upregulation facilitates the growth and progression of many cancers by promoting glycolytic metabolism and antagonizing the mitochondrial permeability transition that precedes multiple cell death pathways. TRAP1 attenuation induces apoptosis in cellular models of cancer, identifying TRAP1 as a potential therapeutic target in cancer. Similar to cytosolic Hsp90 proteins, TRAP1 is also subject to post-translational modifications (PTM) that regulate its function and mediate its impact on downstream effectors, or ‘clients’. However, few effectors have been identified to date. Here, we will discuss the consequence of TRAP1 deregulation in cancer and the impact of post-translational modification on the known functions of TRAP1.

17 August 2022 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
RSRebecca A. Sager
Rebecca A. Sager
FKFarzana Khan
Farzana Khan
LTLorenzo Toneatto
Lorenzo Toneatto
SVSarahBeth D. Votra
SarahBeth D. Votra
SBSarah J. Backe
Sarah J. Backe
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
The molecular chaperone Heat Shock Protein-90 (Hsp90) is known to interact with over 300 client proteins as well as regulatory factors (eg. nucleotide and proteins) that facilitate execution of its role as a chaperone and, ultimately, client protein activation. Hsp90 associates transiently with these molecular modulators during an eventful chaperone cycle, resulting in acquisition of flexible structural conformations, perfectly customized to the needs of each one of its client proteins. Due to the plethora and diverse nature of proteins it supports, the Hsp90 chaperone machinery is critical for normal cellular function particularly in response to stress. In diseases such as cancer, the Hsp90 chaperone machinery is hijacked for processes which encompass many of the hallmarks of cancer, including cell growth, survival, immune response evasion, migration, invasion, and angiogenesis. Elevated levels of extracellular Hsp90 (eHsp90) enhance tumorigenesis and the potential for metastasis. eHsp90 has been considered one of the new targets in the development of anti-cancer drugs as there are various stages of cancer progression where eHsp90 function could be targeted. Our limited understanding of the regulation of the eHsp90 chaperone machinery is a major drawback for designing successful Hsp90-targeted therapies, and more research is still warranted.

26 March 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
MCMahmoud Chehab
Mahmoud Chehab
TCTiffany Caza
Tiffany Caza
KSKamil Skotnicki
Kamil Skotnicki
SLSteve Landas
Steve Landas
GBGennady Bratslavsky
Gennady Bratslavsky
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
Targeting Hsp90 in urothelial carcinoma Targeting Hsp90 in urothelial carcinoma

1 March 2018 in iScience
Verified
Journal Article
Open access
JSJavier Sánchez-Pozo
Javier Sánchez-Pozo
ABAlexander J. Baker-Williams
Alexander J. Baker-Williams
MWMark R Woodford
Mark R Woodford
RBRenee Bullard
Renee Bullard
BWBeiyang Wei
Beiyang Wei
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
The tissue inhibitor of metalloproteinases 2 (TIMP-2) is a specific endogenous inhibitor of matrix metalloproteinase 2 (MMP-2), which is a key enzyme that degrades the extracellular matrix and promotes tumor cell invasion. Although the TIMP-2:MMP-2 complex controls proteolysis, the signaling mechanism by which the two proteins associate in the extracellular space remains unidentified. Here we report that TIMP-2 is phosphorylated outside the cell by secreted c-Src tyrosine kinase. As a consequence, phosphorylation at Y90 significantly enhances TIMP-2 potency as an MMP-2 inhibitor and weakens the catalytic action of the active enzyme. TIMP-2 phosphorylation also appears to be essential for its interaction with the latent enzyme proMMP-2 in vivo. Absence of the kinase or non-phosphorylatable Y90 abolishes TIMP-2 binding to the latent enzyme, ultimately hampering proMMP-2 activation. Together, TIMP-2 phosphorylation by secreted c-Src represents a critical extracellular regulatory mechanism that controls the proteolytic function of MMP-2.

1 January 2014 in Molecular and Cellular Therapies
Verified
Journal Article
Open access
TRTaylor C Remillard
Taylor C Remillard
GBGennady Bratslavsky
Gennady Bratslavsky
SJSandra Jensen-Taubman
Sandra Jensen-Taubman
WSWilliam G Stetler-Stevenson
William G Stetler-Stevenson
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
There has been a recent paradigm shift in the way we target cancer, drawing a greater focus on the role of the tumor microenvironment (TME) in cancer development, progression and metastasis. Within the TME, there is a crosstalk in signaling and communication between the malignant cells and the surrounding extracellular matrix. Matrix metalloproteinases (MMPs) are zinc-dependent endoproteases that have the ability to degrade the matrix surrounding a tumor and mediate tumor growth, angiogenesis and metastatic disease. Their endogenous inhibitors, the Tissue Inhibitors of Metalloproteinases (TIMPs), primarily function to prevent degradation of the ECM via inhibition of MMPs. However, recent studies demonstrate that TIMP family members also possess MMP-independent functions. One TIMP member in particular, TIMP-2, has many distinct properties and functions, that occur independent of MMP inhibition, including the inhibition of tumor growth and reduction of angiogenesis through decreased endothelial cell proliferation and migration. The MMP-independent molecular mechanisms and signaling pathways elicited by TIMP-2 in the TME are described in this review.